Alex Kotzer
Career history of Alex Kotzer
Former positions of Alex Kotzer
| Companies | Position | Start | End |
|---|---|---|---|
Regenera Pharma Ltd.
 Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Chief Executive Officer | 2010-03-24 | - |
| Chairman | 2010-03-24 | - | |
| COMPUGEN LTD. | Director/Board Member | 2009-06-02 | - |
| President | 2005-08-31 | 2009-06-02 |
Training of Alex Kotzer
| Technion-Israel Institute of Technology | Undergraduate Degree |
Statistics
International
| Israel | 4 |
Operational
| Director/Board Member | 1 |
| President | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| COMPUGEN LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Regenera Pharma Ltd.
Regenera Pharma Ltd. Pharmaceuticals: MajorHealth Technology Regenera Pharma Ltd. develops a novel drug candidate, RPH201 for neurological indications. It also focuses on developing a treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), the most common cause of sudden optic nerve-related vison loss in older people. The company is headquartered in Ness-Ziona, Israel. | Health Technology |
- Stock Market
- Insiders
- Alex Kotzer
- Experience
